ICON (ICLR)
(Delayed Data from NSDQ)
$322.06 USD
+1.48 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $321.76 -0.30 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Icon PLC (ICLR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$366.50 | $385.00 | $315.00 | 14.32% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Icon PLC comes to $366.50. The forecasts range from a low of $315.00 to a high of $385.00. The average price target represents an increase of 14.32% from the last closing price of $320.58.
Analyst Price Targets (14)
Broker Rating
Icon PLC currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 15 are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ICLR.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 15 | 15 | 15 | 15 | 15 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/26/2024 | Truist Securities | Jailendra Singh | Strong Buy | Strong Buy |
7/26/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
7/8/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
6/6/2024 | Goldman Sachs | Matthew Sykes | Not Available | Strong Buy |
5/31/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
5/31/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
5/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Charles Rhyee | Strong Buy | Strong Buy |
2/22/2024 | UBS | John N Sourbeer | Strong Buy | Strong Buy |
12/11/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 15 |
Average Target Price | $366.50 |
LT Growth Rate | 15.40% |
Industry | Medical Services |
Industry Rank by ABR | 171 of 253 |
Current Quarter EPS Est: | 3.85 |